No abstract

No abstract

In this paper, a simple, sensitive and precise electroanalytical method was developed using a chemically-reduced graphene-oxide (CRGO)-modified glassy carbon electrode and square wave voltammetry (SWV) for determination of ciprofloxacin in pharmaceutical formulations (tablets) and milk samples. Advantages of this sensor include a potential displacement of 100 mV and a 5-fold current increase for the electrochemical oxidation of ciprofloxacin, which resulted in a highly sensitive sensor, when compared to unmodified electrode. The improved properties of the modified electrode are likely due to the formation of a porous surface evidenced by the change in electrode kinetics (thin-layer diffusion process). The proposed sensor is free from interference of sample matrix (pharmaceutical formulations and low/high-fat milk) avoiding cumbersome processes such as previous separations, solvent extraction, or sample filtration (samples were only diluted in Britton-Robinson buffer solution). The results by SWV showed a limit of detection of 0.21 µmol L -1 (correspondent to 0.069 mg L -1 ), which is lower than the ones obtained using other carbon-based electrodes, relative standard deviations lower than 12%, and satisfactory recoveries in the range from 84 to 109%. The results obtained were statistically similar (95% confidence level) with those performed through high-performance liquid chromatography (HPLC).

Dipyrone (metamizole sodium) is one of the most consumed drugs in the world. In this work a novel analytical method was developed for dipyrone sensing. This method involves the amperometric detection on a chemically‐reduced graphene‐oxide (CRGO)‐modified glassy carbon electrode. Raman spectroscopy and scanning electron microscopy revealed the presence of multilayer graphene layers that contributed to the electrocatalytic oxidation of dipyrone and increase in the electroactive area. Advantages of this sensor include elimination of previous separations, solvent extraction, or sample filtration, low detection limit (0.13 μmol L−1) with a linear range from 48 to 246 μmol L−1 and adequate recovery values (97–103 %). Applied to commercial pharmaceutical samples, this method showed results ranging from 451 to 541 mg of dipyrone per tablet, which agreed with the expected values. The results obtained by amperometry were compared statistically with the official method recommended by the Brazilian Pharmacopoeia (iodometric method), with no significant differences between them at 95 % confidence level. The proposed method is accurate for the monitoring of sodium dipyrone in pharmaceutical formulations, highlighting the lower reagent consumption and interferences in the analytical process.

Novel gold(I) and gold(III) complexes containing derivatives of D-galactose, D-ribose and D-glucono-1,5-lactone as ligands were synthesized and characterized by IR, (1)H, and (13)C NMR, high resolution mass spectra and cyclic voltammetry. The compounds were evaluated in vitro for their cytotoxicity against three types of tumor cells: cervical carcinoma (HeLa) breast adenocarcinoma (MCF-7) and glioblastoma (MO59J) and one non-tumor cell line: human lung fibroblasts (GM07492A). Their antitubercular activity was evaluated as well expressed as the minimum inhibitory concentration (MIC90) in μg/mL. In general, the gold(I) complexes were more active than gold(III) complexes, for example, the gold(I) complex (1) was about 8.8 times and 7.6 times more cytotoxic than gold(III) complex (8) in MO59J and MCF-7 cells, respectively. Ribose and alkyl phosphine derivative complexes were more active than galactose and aryl phosphine complexes. The presence of a thiazolidine ring did not improve the cytotoxicity. The study of the cytotoxic activity revealed effective antitumor activities for the gold(I) complexes, being more active than cisplatin in all the tested tumor cell lines. Gold(I) compounds (1), (2), (3), (4) and (6) exhibited relevant antitubercular activity even when compared with first line drugs such as rifampicin.